Alzamend Neuro, Inc. (ALZN) DCF Valuation

Alzamend Neuro, Inc. (ALZN) DCF Valuation
  • ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
  • ✓ No Se Necesita Experiencia; Fáciles De Seguir

Alzamend Neuro, Inc. (ALZN) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Looking to determine the intrinsic value of Alzamend Neuro, Inc.? Our ALZN DCF Calculator integrates real-world data with comprehensive customization options, enabling you to refine your forecasts and enhance your investment strategies.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2020		 AY2
2021		 AY3
2022		 AY4
2023		 AY5
2024		 FY1
2025		 FY2
2026		 FY3
2027		 FY4
2028		 FY5
2029
Revenue .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 0 0 0 0 0 0 0 0
EBITDA .0 .0 -12.3 -14.8 -9.9 .0 .0 .0 .0 .0
EBITDA, % 100 100 100 100 100 100 100 100 100 100
Depreciation 4.4 5.0 .0 .0 .1 .0 .0 .0 .0 .0
Depreciation, % 100 100 100 100 100 100 100 100 100 100
EBIT -4.4 -5.0 -12.3 -14.9 -9.9 .0 .0 .0 .0 .0
EBIT, % 100 100 100 100 100 100 100 100 100 100
Total Cash .1 1.9 14.1 5.1 .4 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .2 .0 .0 .0 .0
Account Receivables, % 100 100 100 100 100
Inventories .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Inventories, % 100 100 100 100 100 100 100 100 100 100
Accounts Payable .9 .5 1.2 2.9 2.9 .0 .0 .0 .0 .0
Accounts Payable, % 100 100 100 100 100 100 100 100 100 100
Capital Expenditure .0 .0 -.1 .0 -.1 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 100 100 100 0 0 0 0 0
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -4.4 -5.1 -12.4 -14.9 -9.9 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF .7 -.4 -11.8 -13.1 -10.0 -2.9 .0 .0 .0 .0
WACC, % 5.14 5.14 5.14 5.14 5.14 5.14 5.14 5.14 5.14 5.14
PV UFCF
SUM PV UFCF -2.8
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value -3
Net Debt 0
Equity Value -3
Diluted Shares Outstanding, MM 1
Equity Value Per Share -4.00

What You Will Get

  • Real Alzamend Neuro Data: Preloaded financials – from revenue to EBIT – based on actual and projected figures for Alzamend Neuro, Inc. (ALZN).
  • Full Customization: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates specific to Alzamend Neuro.
  • Instant Valuation Updates: Automatic recalculations to analyze the impact of changes on Alzamend Neuro’s fair value.
  • Versatile Excel Template: Tailored for quick edits, scenario testing, and detailed projections for Alzamend Neuro, Inc. (ALZN).
  • Time-Saving and Accurate: Skip building models from scratch while maintaining precision and flexibility for Alzamend Neuro.

Key Features

  • Comprehensive DCF Calculator: Offers detailed unlevered and levered DCF valuation models tailored for Alzamend Neuro, Inc. (ALZN).
  • WACC Calculator: Features a pre-built Weighted Average Cost of Capital sheet with customizable inputs specific to Alzamend Neuro, Inc. (ALZN).
  • Customizable Forecast Assumptions: Adjust growth rates, capital expenditures, and discount rates to fit Alzamend Neuro, Inc. (ALZN) projections.
  • Integrated Financial Ratios: Evaluate profitability, leverage, and efficiency ratios relevant to Alzamend Neuro, Inc. (ALZN).
  • Interactive Dashboard and Charts: Visual representations of key valuation metrics for straightforward analysis of Alzamend Neuro, Inc. (ALZN).

How It Works

  1. Step 1: Download the Excel file.
  2. Step 2: Review pre-entered Alzamend Neuro data (historical and projected).
  3. Step 3: Adjust key assumptions (yellow cells) based on your analysis.
  4. Step 4: View automatic recalculations for Alzamend Neuro’s intrinsic value.
  5. Step 5: Use the outputs for investment decisions or reporting.

Why Choose This Calculator for Alzamend Neuro, Inc. (ALZN)?

  • User-Friendly Interface: Tailored for both novices and seasoned professionals.
  • Customizable Inputs: Adjust parameters easily to suit your financial analysis.
  • Real-Time Valuation: Observe immediate updates to Alzamend Neuro’s valuation as you modify inputs.
  • Preloaded Data: Comes with Alzamend Neuro’s actual financial figures for swift assessments.
  • Relied Upon by Experts: Favored by investors and analysts for making well-informed choices.

Who Should Use This Product?

  • Investors: Assess Alzamend Neuro’s valuation before making stock transactions.
  • CFOs and Financial Analysts: Enhance valuation methodologies and evaluate financial forecasts.
  • Startup Founders: Understand the valuation strategies of innovative biotech companies like Alzamend Neuro.
  • Consultants: Provide comprehensive valuation analyses for clients in the healthcare sector.
  • Students and Educators: Utilize real-time data to explore and teach valuation principles.

What the Template Contains

  • Historical Data: Includes Alzamend Neuro’s past financials and baseline forecasts.
  • DCF and Levered DCF Models: Detailed templates to calculate Alzamend Neuro’s intrinsic value.
  • WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
  • Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
  • Quarterly and Annual Statements: A complete breakdown of Alzamend Neuro’s financials.
  • Interactive Dashboard: Visualize valuation results and projections dynamically.

No products were found matching.